ADLM Issues Guidance on Laboratory Testing for Gender-Diverse Patients
The recommendations provide a framework for interpreting results affected by hormone therapy and improving electronic health record practices.
Read More
Search Results for: liver disease
InterVenn, Aranscia Expand Access to Blood-Based Ovarian Cancer Test
The expanded commercialization agreement aims to increase availability of the GlycoKnow Ovarian laboratory-developed test through Aranscia’s clinical workflow and technology platforms.
Read More
Roche Launches New DNA Sequencing Platform AXELIOS 1
Roche has launched AXELIOS 1, a single-molecule sequencing platform that uses sequencing by expansion technology to deliver same-day whole-genome results.
Read More
National Coverage Agreement Secured for Cerebrospinal Fluid Cancer Test
CNSide Diagnostics has secured a national agreement with Elevance Health, expanding access to its CSF Tumor Cell Enumeration assay to 45.4 million more people in the US, Plus Therapeutics announced.
Read More
Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read More